Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,807,000 | 3,116,000 | 1,545,000 | 4,046,000 | 2,973,000 |
| Depreciation Amortization | 486,000 | 315,000 | 157,000 | 635,000 | 495,000 |
| Income taxes - deferred | -20,000 | -79,000 | -41,000 | 32,000 | -10,000 |
| Accounts receivable | -331,000 | -385,000 | -271,000 | -178,000 | -225,000 |
| Other Working Capital | -155,000 | -45,000 | -213,000 | -235,000 | -631,000 |
| Other Operating Activity | 1,028,000 | 721,000 | 299,000 | 871,000 | 226,000 |
| Operating Cash Flow | $5,815,000 | $3,643,000 | $1,476,000 | $5,171,000 | $2,828,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -197,000 | -129,000 | -69,000 | -330,000 | -232,000 |
| Net Acquisitions | N/A | N/A | N/A | -8,648,000 | -8,648,000 |
| Purchase Of Investment | -600,000 | -586,000 | -489,000 | -924,000 | -416,000 |
| Sale Of Investment | 996,000 | 377,000 | 263,000 | 3,484,000 | 3,479,000 |
| Purchase Sale Intangibles | -400,000 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -400,000 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-201,000 | $-338,000 | $-295,000 | $-6,418,000 | $-5,817,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 0 | 0 | 5,709,000 | 5,709,000 |
| Debt Issued | N/A | 0 | 0 | 4,452,000 | 4,452,000 |
| Debt Repayment | -500,000 | -500,000 | N/A | N/A | N/A |
| Common Stock Repurchased | N/A | 0 | 0 | -6,096,000 | -6,096,000 |
| Other Financing Activity | 281,000 | 179,000 | 26,000 | -5,605,000 | -5,621,000 |
| Financing Cash Flow | $-219,000 | $-321,000 | $26,000 | $-1,540,000 | $-1,556,000 |
| Exchange Rate Effect | -25,000 | -4,000 | -8,000 | 8,000 | 12,000 |
| Beginning Cash Position | 4,234,000 | 4,234,000 | 4,234,000 | 7,013,000 | 7,013,000 |
| End Cash Position | 9,604,000 | 7,214,000 | 5,433,000 | 4,234,000 | 2,480,000 |
| Net Cash Flow | $5,370,000 | $2,980,000 | $1,199,000 | $-2,779,000 | $-4,533,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 5,815,000 | 3,643,000 | 1,476,000 | 5,171,000 | 2,828,000 |
| Capital Expenditure | -197,000 | -129,000 | -69,000 | -330,000 | -232,000 |
| Free Cash Flow | 5,618,000 | 3,514,000 | 1,407,000 | 4,841,000 | 2,596,000 |